Table 2 Characteristics of neutropenic episodes
Neutropenic episodes in period I | Neutropenic episodes in period II | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Total | Duration in days | Carbapenem started | Total | Duration in days | Carbapenem started | |||||
n | median (IQR) | n | % | n | median (IQR) | n | % | |||
Chemotherapy | 128 | 19 | (14–26) | 105 | (82) | 153 | 18 | (13–25) | 123 | (80) |
Allogenic SCT | 34 | 11 | (8–17) | 11 | (32) | 47 | 12 | (9–26) | 29 | (62) |
Total | 162 | 18 | (12–25) | 116 | (72) | 200 | 18 | (12–26) | 152 | (76) |